Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 3 (March)

1. Altered expression of neurotrophic factors in patients with major depression.
   J Psychiatr Res. [Abstract] [Full-text]
2. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
   J Affect Disord, 107(1): 23-8. [Abstract] [Full-text]
3. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder.
   J Affect Disord, 107(1): 53-62. [Abstract] [Full-text]
4. Predominant polarity in bipolar disorder: diagnostic implications.
   J Affect Disord, 107(1): 45-51. [Abstract] [Full-text]
5. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
   J Affect Disord, 107(1): 307-15. [Abstract] [Full-text]
6. Accuracy of recall for mania symptoms using a three month timeline follow-back interview.
   J Affect Disord, 107(1): 271-4. [Abstract] [Full-text]
7. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
   J Affect Disord, 107(1): 117-26. [Abstract] [Full-text]
8. Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning.
   J Affect Disord, 107(1): 275-9. [Abstract] [Full-text]
9. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
   J Affect Disord, 107(1): 169-74. [Abstract] [Full-text]
10. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode.
    J Affect Disord, 107(1): 89-94. [Abstract] [Full-text]
11. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk.
    J Affect Disord, 107(1): 293-8. [Abstract] [Full-text]
12. Is donepezil useful for improving cognitive dysfunction in bipolar disorder?
    J Affect Disord, 107(1): 237-40. [Abstract] [Full-text]
13. Family environment patterns in families with bipolar children.
    J Affect Disord, 107(1): 299-305. [Abstract] [Full-text]
14. Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity.
    Neurosci Lett, 432(1): 54-7. [Abstract] [Full-text]
15. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder.
    Psychiatry Res, 158(1): 75-8. [Abstract] [Full-text]
16. Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling.
    Mol Cell Neurosci, 37(3): 440-53. [Abstract] [Full-text]
17. Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder.
    Br J Psychiatry, 192: 197-201. [Abstract] [Full-text]
18. Medical burden in late-life bipolar and major depressive disorders.
    Am J Geriatr Psychiatry, 16(3): 194-200. [Abstract] [Full-text]
19. The ascent into mania: A review of psychological processes associated with the development of manic symptoms.
    Clin Psychol Rev, 28(3): 494-520. [Abstract] [Full-text]
20. The Prospective Course of Rapid-Cycling Bipolar Disorder: Findings From the STEP-BD.
    Am J Psychiatry, 165(3): 370-7. [Abstract] [Full-text]
21. Prefrontal function and activation in bipolar disorder and schizophrenia.
    Am J Psychiatry, 165(3): 378-84. [Abstract] [Full-text]
22. Facial emotion labeling deficits in children and adolescents at risk for bipolar disorder.
    Am J Psychiatry, 165(3): 385-9. [Abstract] [Full-text]
23. Medication effects in neuroimaging studies of bipolar disorder.
    Am J Psychiatry, 165(3): 313-20. [Abstract] [Full-text]
24. Is the perimenopause a time of increased risk of recurrence in women with a history of bipolar affective postpartum psychosis? A case series.
    Arch Womens Ment Health, 11(1): 75-8. [Abstract] [Full-text]
25. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
26. Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
27. A simulated genetic structure for bipolar illness.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
28. Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: Preliminary results.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(3): 673-8. [Abstract] [Full-text]
29. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.
    Am J Hum Genet, 82(3): 696-711. [Abstract] [Full-text]
30. MRI study of the cerebellum in young bipolar patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(3): 613-9. [Abstract] [Full-text]
31. Does diagnostic classification of early-onset psychosis change over follow-up?
    Child Psychiatry Hum Dev, 39(2): 137-45. [Abstract] [Full-text]
32. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.
    Acta Psychiatr Scand, 117(4): 283-8. [Abstract] [Full-text]
33. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.
    Acta Psychiatr Scand, 117(4): 313-8. [Abstract] [Full-text]
34. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    J Neurosci, 28(10): 2576-88. [Abstract] [Full-text]
35. Evaluation of clinical prognostic models for suicide attempts after a major depressive episode.
    Acta Psychiatr Scand, 117(4): 244-52. [Abstract] [Full-text]
36. Underdiagnosis of comorbid mental illness in repeat DUI offenders mandated to treatment.
    J Subst Abuse Treat, 34(3): 320-5. [Abstract] [Full-text]
37. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder.
    Biol Psychiatry, 63(7): 678-85. [Abstract] [Full-text]
38. Effect of bipolar disorder on left frontal cortical responses to goals differing in valence and task difficulty.
    Biol Psychiatry, 63(7): 693-8. [Abstract] [Full-text]
39. Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder.
    Schizophr Res, 100(1): 334-41. [Abstract] [Full-text]
40. Personality in relation to genetic liability for schizophrenia and bipolar disorder: Differential associations with the COMT Val(108/158)Met polymorphism.
    Schizophr Res, 100(1): 316-24. [Abstract] [Full-text]
41. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes.
    Schizophr Res, 100(1): 281-90. [Abstract] [Full-text]
42. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: A 4-year follow-up naturalistic study.
    J Affect Disord. [Abstract] [Full-text]
43. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study.
    Fertil Steril, 89(3): 685-92. [Abstract] [Full-text]
44. Structural brain correlates of response inhibition in Bipolar Disorder I.
    J Psychopharmacol, 22(2): 138-43. [Abstract] [Full-text]
45. An fMRI study of the interface between affective and cognitive neural circuitry in pediatric bipolar disorder.
    Psychiatry Res, 162(3): 244-55. [Abstract] [Full-text]
46. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania.
    Mol Psychiatry. [Abstract] [Full-text]
47. The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions.
    Mol Psychiatry. [Abstract] [Full-text]
48. ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia.
    Neuropsychopharmacology, 33(5): 957-70. [Abstract] [Full-text]
49. Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: a correlation with BDNF expression.
    PLoS ONE, 3(3): e1784. [Abstract] [Full-text]
50. Pre-pubertal paediatric bipolar disorder: a controversy from America.
    Australas Psychiatry, 16(2): 80-4; discussion 85-6. [Abstract] [Full-text]
51. Acute treatment response and its predictors in patients with first-episode psychosis in Iran.
    Australas Psychiatry, 16(2): 125-9. [Abstract] [Full-text]
52. NCAM in Neuropsychiatric and Neurodegenerative Disorders.
    Neurochem Res. [Abstract] [Full-text]
53. Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits.
    Neurosci Lett, 434(1): 41-5. [Abstract] [Full-text]
54. Assessment of medication management ability in middle-aged and older adults with bipolar disorder.
    J Clin Psychopharmacol, 28(2): 225-9. [Abstract] [Full-text]
55. Vagal tone and temperament as predictors of emotion regulation strategies in young children.
    Dev Psychobiol, 50(3): 205-16. [Abstract] [Full-text]
56. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.
    J Clin Psychopharmacol, 28(2): 203-9. [Abstract] [Full-text]
57. Chromosome 10q harbors a susceptibility locus for bipolar disorder in Ashkenazi Jewish families.
    Mol Psychiatry, 13(4): 442-50. [Abstract] [Full-text]
58. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins.
    Mol Psychiatry, 13(4): 429-41. [Abstract] [Full-text]
59. Oxcarbazepine may induce psychotic symptoms in Parkinson's disease.
    Epilepsy Behav, 12(3): 492-3. [Abstract] [Full-text]
60. Lithium toxicity and the parturient: case report and literature review.
    Int J Obstet Anesth, 17(2): 164-9. [Abstract] [Full-text]
61. No change to grey and white matter volumes in bipolar I disorder patients.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
62. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol.
    Mol Psychiatry. [Abstract] [Full-text]
63. Familial risks for depression among siblings based on hospitalizations in Sweden.
    Psychiatr Genet, 18(2): 80-4. [Abstract] [Full-text]
64. Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment.
    Psychiatr Genet, 18(2): 64-72. [Abstract] [Full-text]
65. Association analysis of the pituitary adenylate cyclase-activating polypeptide (PACAP/ADCYAP1) gene in bipolar disorder.
    Psychiatr Genet, 18(2): 53-8. [Abstract] [Full-text]
66. Association study of serotonin system genes in childhood-onset mood disorder.
    Psychiatr Genet, 18(2): 47-52. [Abstract] [Full-text]
67. Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex.
    Neurochem Res, 33(5): 861-6. [Abstract] [Full-text]
68. Genetic Variations of Human Neuropsin Gene and Psychiatric Disorders: Polymorphism Screening and Possible Association with Bipolar Disorder and Cognitive Functions.
    Neuropsychopharmacology. [Abstract] [Full-text]
69. Recognizing thyrotoxicosis in a patient with bipolar mania: a case report.
    Ann Gen Psychiatry, 7: 3. [Abstract] [Full-text]
70. Impact of depressive mixed state in an emergency psychiatry setting: A marker of bipolar disorder and a possible risk factor for emergency hospitalization.
    J Affect Disord. [Abstract] [Full-text]
71. Glucocorticoid antagonists in neuropsychotic disorders.
    Eur J Pharmacol, 583(2): 358-64. [Abstract] [Full-text]
72. Corticosteroid receptor polymorphisms: Determinants of vulnerability and resilience.
    Eur J Pharmacol, 583(2): 303-11. [Abstract] [Full-text]
73. Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists.
    Eur Psychiatry, 23(3): 169-77. [Abstract] [Full-text]
74. Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials.
    J Psychiatr Pract, 14(2): 77-85. [Abstract] [Full-text]
75. Quetiapine: treatment for substance abuse and drug of abuse.
    Am J Health Syst Pharm, 65(7): 611-8. [Abstract] [Full-text]
76. Promoter Variant in the GRK3 Gene Associated with Bipolar Disorder Alters Gene Expression.
    Biol Psychiatry. [Abstract] [Full-text]
77. A case of hemoperfusion and L-carnitine management in valproic acid overdose.
    Am J Emerg Med, 26(3): 388.e3-4. [Abstract] [Full-text]
78. Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders.
    J Psychiatr Res, 42(7): 569-77. [Abstract] [Full-text]
79. Psychopathology in adolescent and young adult criminal offenders (15-21 years) in Sweden.
    Soc Psychiatry Psychiatr Epidemiol, 43(4): 319-24. [Abstract] [Full-text]
80. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3).
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
81. A marked effect of electroconvulsive stimulation on behavioral aberration of mice with neuron-specific mitochondrial DNA defects.
    PLoS ONE, 3(3): e1877. [Abstract] [Full-text]
82. The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis.
    Epilepsia. [Abstract] [Full-text]
83. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
    Neuropathology, 28(2): 143-50. [Abstract] [Full-text]
84. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy.
    Epilepsia, 49(4): 650-6. [Abstract] [Full-text]
85. Accuracy of brief and full forms of the Child Mania Rating Scale.
    J Clin Psychol, 64(4): 368-81. [Abstract] [Full-text]
86. Comparing the psychometric properties of multiple teacher report instruments as predictors of bipolar disorder in children and adolescents.
    J Clin Psychol, 64(4): 382-401. [Abstract] [Full-text]
87. Suicidal risk in young adult offspring of mothers with bipolar or major depressive disorder: a longitudinal family risk study.
    J Clin Psychol, 64(4): 531-40. [Abstract] [Full-text]
88. Development of the treatment attitudes questionnaire in bipolar disorder.
    J Clin Psychol, 64(4): 466-81. [Abstract] [Full-text]
89. Parent-child interactions in pediatric bipolar disorder.
    J Clin Psychol, 64(4): 422-37. [Abstract] [Full-text]
90. Correlates of high expressed emotion attitudes among parents of bipolar adolescents.
    J Clin Psychol, 64(4): 438-49. [Abstract] [Full-text]
91. Do current beliefs predict hypomanic symptoms beyond personality style? Factor analysis of the hypomanic attitudes and positive predictions inventory (HAPPI) and its association with hypomanic symptoms in a student population.
    J Clin Psychol, 64(4): 450-65. [Abstract] [Full-text]
92. Early childhood temperament in pediatric bipolar disorder and attention deficit hyperactivity disorder.
    J Clin Psychol, 64(4): 402-21. [Abstract] [Full-text]
93. Pharmacotherapy of Mood Disorders.
    Annu Rev Clin Psychol, 4: 53-91. [Abstract] [Full-text]
94. Enhanced cancer risk among patients with bipolar disorder.
    J Affect Disord, 108(1): 43-8. [Abstract] [Full-text]
95. Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
    J Affect Disord, 108(1): 129-34. [Abstract] [Full-text]
96. Bipolar disorders and affective temperaments: a national family study testing the "endophenotype" and "subaffective" theses using the TEMPS-A Buenos Aires.
    J Affect Disord, 108(1): 25-32. [Abstract] [Full-text]
97. Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
    J Affect Disord, 108(1): 1-9. [Abstract] [Full-text]
98. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study.
    J Affect Disord, 108(1): 121-7. [Abstract] [Full-text]
99. Are bipolar mood symptoms affected by the phase of the menstrual cycle?
    J Womens Health (Larchmt), 17(3): 473-8. [Abstract] [Full-text]
100. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
     Neurochem Int, 52(6): 1297-303. [Abstract] [Full-text]
101. Symptom structure of acute mania: a factor study of the 24-item Brief Psychiatric Rating Scale in a national sample of patients hospitalized for a manic episode.
     J Affect Disord, 108(1): 183-9. [Abstract] [Full-text]
102. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
     J Affect Disord, 108(1): 71-86. [Abstract] [Full-text]
103. Seasonality of three dimensions of mania: psychosis, aggression and suicidality.
     J Affect Disord, 108(1): 95-100. [Abstract] [Full-text]
104. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders.
     J Affect Disord, 108(1): 49-58. [Abstract] [Full-text]
105. Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample.
     J Affect Disord, 108(1): 177-82. [Abstract] [Full-text]
106. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.
     J Affect Disord, 108(1): 59-70. [Abstract] [Full-text]
107. Whole blood BDNF levels in healthy twins discordant for affective disorder: association to life events and neuroticism.
     J Affect Disord, 108(1): 165-9. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.